Ticker
ICCCCompany Name
IMMUCELL CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Gross Profit | Gross Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 10.59M | 37.44% | $ 28.27M |
3/31/2025 | $ 9M | 32.96% | $ 27.3M |
12/31/2024 | $ 7.94M | 29.97% | $ 26.49M |
9/30/2024 | $ 6.37M | 26.71% | $ 23.84M |
6/30/2024 | $ 6.05M | 26.05% | $ 23.22M |
3/31/2024 | $ 5.86M | 27.55% | $ 21.28M |
12/31/2023 | $ 3.87M | 22.15% | $ 17.47M |
9/30/2023 | $ 3.6M | 22.13% | $ 16.29M |
6/30/2023 | $ 4.18M | 26.67% | $ 15.69M |
3/31/2023 | $ 4.85M | 30.26% | $ 16.01M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Revenues
(=) Gross %
Gross % for IMMUCELL CORP is calculated as follows: GP [ $ 7.08M ] / Revenues [ $ 15.23M ]
(=) Gross % [ 46.48% ]
Minimum
Sep 30, 2023
Maximum
Mar 31, 2022
Average
Median
filtered constituents | 3.81K |
---|---|
min | -72.25% |
max | 150.26% |
average | 53.11% |
median | 49.46% |
std | 31.58% |